That children present with hepatic encephalopathy (HE) in the setting of acute liver failure (ALF) is accepted and a recognized prognostic factor for survival [1,2]. What is less understood is the impact of chronic liver disease (CLD) on the neuro-cognitive and –psychiatric development and outcomes of children with chronic liver disease early in life. Much is extrapolated from the adult literature or from work in experimental models. But what distinguishes children is that central nervous system development, characterized by massive brain growth, is ongoing at the time of liver disease, arguably exposing them to unique risks, something which cannot be extrapolated from adults. The purpose of this brief review is to summarize what is distinctive about the neurocognition of children with CLD or having presented CLD or portosystemic bypass in childhood.

Mclin, V., D'Antiga, L. (2022). The current pediatric perspective on type B and C hepatic encephalopathy. ANALYTICAL BIOCHEMISTRY, 643 [10.1016/j.ab.2022.114576].

The current pediatric perspective on type B and C hepatic encephalopathy

D'Antiga L.
2022

Abstract

That children present with hepatic encephalopathy (HE) in the setting of acute liver failure (ALF) is accepted and a recognized prognostic factor for survival [1,2]. What is less understood is the impact of chronic liver disease (CLD) on the neuro-cognitive and –psychiatric development and outcomes of children with chronic liver disease early in life. Much is extrapolated from the adult literature or from work in experimental models. But what distinguishes children is that central nervous system development, characterized by massive brain growth, is ongoing at the time of liver disease, arguably exposing them to unique risks, something which cannot be extrapolated from adults. The purpose of this brief review is to summarize what is distinctive about the neurocognition of children with CLD or having presented CLD or portosystemic bypass in childhood.
Articolo in rivista - Articolo scientifico
Ammonium; Children; Chronic liver disease; Encephalopathy; Glutamine; Portosystemic shunting; Type B; Type C;
English
29-gen-2022
2022
643
114576
none
Mclin, V., D'Antiga, L. (2022). The current pediatric perspective on type B and C hepatic encephalopathy. ANALYTICAL BIOCHEMISTRY, 643 [10.1016/j.ab.2022.114576].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/473809
Citazioni
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
Social impact